Log In
Print
BCIQ
Print
Print this Print this
 

Signifor, pasireotide (SOM230)

  Manage Alerts
Collapse Summary General Information
Company Novartis AG
DescriptionSomatostatin analog
Molecular Target Somatostatin receptor
Mechanism of Action 
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today